Bayer AG’s 16.3 billion euro ($19.6 billion) offer for drugmaker Schering AG was embraced enthusiastically by its target Friday as German rival Merck abandoned its own takeover offer.
Bayer’s bid late Thursday trumped Merck’s hostile 14.9 billion ($17.9 billion) offer for Schering made on March 13.
